Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
August-2018 Volume 16 Issue 2

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
August-2018 Volume 16 Issue 2

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

Application of a novel targeting nanoparticle contrast agent combined with magnetic resonance imaging in the diagnosis of intraductal papillary mucinous neoplasm

Retraction in: /10.3892/etm.2024.12720
  • Authors:
    • Min Sun
    • Liqing Kang
    • Yanchao Cui
    • Guoce Li
  • View Affiliations / Copyright

    Affiliations: NMR Department, Cangzhou Central Hospital, Cangzhou, Hebei 061000, P.R. China, Emergency Department, Beijing University of Chinese Medicine, The Third Affiliated Hospital, Beijing 100029, P.R. China
    Copyright: © Sun et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Pages: 1216-1224
    |
    Published online on: June 22, 2018
       https://doi.org/10.3892/etm.2018.6349
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Intraductal papillary mucinous neoplasm (IPMN) is a severe disease with macroscopic visible mucin secretion that primarily occurs in biliary tracts or pancreatic ducts. In comparison with standard diagnostic imaging, probing the molecular abnormalities associated with the initial stages of diseases rather than imaging the end effects markedly improves the accuracy of diagnosis. In the present study, magnetic resonance imaging (MRI) in combination with the contrast agent PEGylated magnetoliposome consisting of gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid (Gd‑EOB‑DTPA) and target molecules of IPMN were investigated in the diagnosis of patients with suspected IPMN. The present investigation indicated that the novel targeting nanoparticle contrast agent targeted platelet‑derived growth factor receptor‑β and RET, and maintained a high affinity with tumor markers located on the IPMN surface. The novel targeting nanoparticle contrast agent combined with MRI exhibited increased sensitivity in diagnosing early‑stage patients with IPMN. Furthermore, image quality was improved following the use of the novel targeting nanoparticle contrast agent combined with MRI compared with standard MRI. The targeting nanoparticle contrast agent retained sufficient affinity and was present for an adequate amount of time to observe the tumor mass in papillae using MRI. Notably, the targeting nanoparticle contrast agent was metabolized at 12 h post‑injection. In conclusion, these outcomes indicate that the novel targeting nanoparticle contrast agent combined with MRI improved image quality and sensitivity compared with standard MRI, which suggests that this approach may be promising for clinical detection in patients with suspected IPMN.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

View References

1 

Chick JF, Chen JX, Bennett SJ, Chauhan NR, Reddy SN, Gade T, Watts MM and Nadolski GJ: Incidental regression of a suspected pancreatic intraductal papillary mucinous neoplasm after nontarget embolization. J Vasc Interv Radiol. 27:922–923. 2016. View Article : Google Scholar : PubMed/NCBI

2 

Chang X, Li J, Jiang Y, Li Y, Lu Z and Chen J: Intraductal papillary mucinous neoplasm of pancreas: Analysis of the clinicopathologic features and prognosis. Zhonghua Bing Li Xue Za Zhi. 45:159–164. 2016.(In Chinese). PubMed/NCBI

3 

Roch AM, Rosati CM, Cioffi JL, Ceppa EP, DeWitt JM, Al-Haddad MA, House MG, Zyromski NJ, Nakeeb A and Schmidt CM: Intraductal papillary mucinous neoplasm of the pancreas, one manifestation of a more systemic disease? Am J Surg. 211:512–518. 2016. View Article : Google Scholar : PubMed/NCBI

4 

Suzuki Y, Nakazato T, Yokoyama M, Kogure M, Matsuki R, Abe N, Mori T, Ohkura Y and Sugiyama M: Development and potential utility of a new scoring formula for prediction of malignant intraductal papillary mucinous neoplasm of the pancreas. Pancreas. 45:1227–1232. 2016. View Article : Google Scholar : PubMed/NCBI

5 

Vitali F, Strobel D, Pfeifer L, Heinrich M, Wachter D, Neurath MF and Wildner D: Neuroendocrine tumor of the pancreas with cystic appearance mimicking a progressive intraductal papillary mucinous neoplasm: Pitfall in medical imaging. Endoscopy. 48:E302–E303. 2016. View Article : Google Scholar : PubMed/NCBI

6 

Trindade AJ, Sejpal DV and Sideridis K: Digital pancreatoscopy in the management of main duct intraductal papillary mucinous neoplasm. Gastrointest Endosc. 84:1060–1061. 2016. View Article : Google Scholar : PubMed/NCBI

7 

Escalon JG, Gerst S, Porembka M, Allen PJ and Do RK: Imaging comparison of tubular and colloid pancreatic adenocarcinoma arising from intraductal papillary mucinous neoplasm on multidetector CT. Clin Imaging. 40:1195–1199. 2016. View Article : Google Scholar : PubMed/NCBI

8 

Hong HS and Kim MJ: Diagnosis of pancreatic intraductal papillary mucinous neoplasm. Korean J Gastroenterol. 52:207–213. 2008.(In Korean). PubMed/NCBI

9 

Tanaka M: Intraductal papillary mucinous neoplasm of the pancreas: Diagnosis and treatment. Pancreas. 28:282–288. 2004. View Article : Google Scholar : PubMed/NCBI

10 

Ebell MH, Culp MB and Radke TJ: A systematic review of symptoms for the diagnosis of ovarian cancer. Am J Prev Med. 50:384–394. 2016. View Article : Google Scholar : PubMed/NCBI

11 

Mennella S, Paparo F, Revelli M, Baccini P, Secondini L, Barbagallo S, Friedman D and Garlaschi A: Magnetic resonance imaging of breast cancer: Does the time interval between biopsy and MRI influence MRI-pathology discordance in lesion sizing? Acta Radiol. 58:800–808. 2016. View Article : Google Scholar : PubMed/NCBI

12 

Karahaliou A, Vassiou K, Arikidis NS, Skiadopoulos S, Kanavou T and Costaridou L: Assessing heterogeneity of lesion enhancement kinetics in dynamic contrast-enhanced MRI for breast cancer diagnosis. Br J Radiol. 83:296–309. 2010. View Article : Google Scholar : PubMed/NCBI

13 

Franchini Comes M, Baldi G, Bonacchi D, Gentili D, Giudetti G, Lascialfari A, Corti M, Marmorato P, Ponti J, Micotti E, et al: Bovine serum albumin-based magnetic nanocarrier for MRI diagnosis and hyperthermic therapy: A potential theranostic approach against cancer. Small. 6:366–370. 2010. View Article : Google Scholar : PubMed/NCBI

14 

Nam EJ, Yun MJ, Oh YT, Kim JW, Kim JH, Kim S, Jung YW, Kim SW and Kim YT: Diagnosis and staging of primary ovarian cancer: Correlation between PET/CT, doppler US and CT or MRI. Gynecol Oncol. 116:389–394. 2010. View Article : Google Scholar : PubMed/NCBI

15 

Hong GS, Byun JH, Kim JH, Kim HJ, Lee SS, Hong SM and Lee MG: Thread sign in biliary intraductal papillary mucinous neoplasm: A novel specific finding for MRI. Eur Radiol. 26:3112–3120. 2016. View Article : Google Scholar : PubMed/NCBI

16 

Mazzei MA, Guerrini S, Mazzei FG, Squitieri Cioffi N, Notaro D, de Donato G, Galzerano G, Sacco P, Setacci F, Volterrani L and Setacci C: Follow-up of endovascular aortic aneurysm repair: Preliminary validation of digital tomosynthesis and contrast enhanced ultrasound in detection of medium-to long-term complications. World J Radiol. 8:530–536. 2016. View Article : Google Scholar : PubMed/NCBI

17 

Schalk S, Demi L, Bouhouch N, Kuenen MPJ, Postema AW, de la Rosette JJMCH, Wijkstra H, Tjalkens TJ and Mischi M: Contrast-enhanced ultrasound angiogenesis imaging by mutual information analysis for prostate cancer localization. IEEE Trans Biomed Eng. 64:661–670. 2017. View Article : Google Scholar : PubMed/NCBI

18 

DiMaio CJ, Weis-Garcia F, Bagiella E, Tang LH and Allen PJ: Pancreatic cyst fluid concentration of high-mobility group A2 protein acts as a differential biomarker of dysplasia in intraductal papillary mucinous neoplasm. Gastrointest Endosc. 83:1205–1209. 2016. View Article : Google Scholar : PubMed/NCBI

19 

Iannicelli E, Carbonetti F, Di Pietropaolo M, Federici GF, Capurso G and David V: Magnetic resonance cholangiopancreatography with secretin stimulation in the diagnosis of intraductal papillary mucinous neoplasm: A paradigmatic case report. Case Rep Radiol. 2014:8203592014.PubMed/NCBI

20 

Taeger J, Moser C, Hellerbrand C, Mycielska ME, Glockzin G, Schlitt HJ, Geissler EK, Stoeltzing O and Lang SA: Targeting FGFR/PDGFR/VEGFR impairs tumor growth, angiogenesis and metastasis by effects on tumor cells, endothelial cells and pericytes in pancreatic cancer. Mol Cancer Ther. 10:2157–2167. 2011. View Article : Google Scholar : PubMed/NCBI

21 

Cavel O, Shomron O, Shabtay A, Vital J, Trejo-Leider L, Weizman N, Krelin Y, Fong Y, Wong RJ, Amit M and Gil Z: Endoneurial macrophages induce perineural invasion of pancreatic cancer cells by secretion of GDNF and activation of RET tyrosine kinase receptor. Cancer Res. 72:5733–5743. 2012. View Article : Google Scholar : PubMed/NCBI

22 

Liu H, Ma Q and Li J: High glucose promotes cell proliferation and enhances GDNF and RET expression in pancreatic cancer cells. Mol Cell Biochem. 347:95–101. 2011. View Article : Google Scholar : PubMed/NCBI

23 

Donahue TR and Hines OJ: CXCR2 and RET single nucleotide polymorphisms in pancreatic cancer. World J Surg. 33:710–715. 2009. View Article : Google Scholar : PubMed/NCBI

24 

Mi P, Kokuryo D, Cabral H, Kumagai M, Nomoto T, Aoki I, Terada Y, Kishimura A, Nishiyama N and Kataoka K: Hydrothermally synthesized PEGylated calcium phosphate nanoparticles incorporating Gd-DTPA for contrast enhanced MRI diagnosis of solid tumors. J Control Release. 174:63–71. 2014. View Article : Google Scholar : PubMed/NCBI

25 

Liang M, Zhao J, Xie B, Li C, Yin X, Cheng L, Wang J and Zhang L: MR liver imaging with Gd-EOB-DTPA: The need for different delay times of the hepatobiliary phase in patients with different liver function. Eur J Radiol. 85:546–552. 2016. View Article : Google Scholar : PubMed/NCBI

26 

Stangenberg L, Shuja F, Carelsen B, Elenbaas T, Wyers MC and Schermerhorn ML: A novel tool for three-dimensional roadmapping reduces radiation exposure and contrast agent dose in complex endovascular interventions. J Vasc Surg. 62:448–455. 2015. View Article : Google Scholar : PubMed/NCBI

27 

Sahibzada I, Batura D and Hellawell G: Validating multiparametric MRI for diagnosis and monitoring of prostate cancer in patients for active surveillance. Int Urol Nephrol. 48:529–533. 2016. View Article : Google Scholar : PubMed/NCBI

28 

Angelov KG, Vasileva MB, Grozdev KS, Sokolov MB and Todorov G: Clinical and pathological characteristics and prognostic factors for gastric cancer survival in 155 patients in Bulgaria. Hepatogastroenterology. 61:2421–2424. 2014.PubMed/NCBI

29 

Frithiof H, Welinder C, Larsson AM, Rydén L and Aaltonen K: A novel method for downstream characterization of breast cancer circulating tumor cells following CellSearch isolation. J Transl Med. 13:1262015. View Article : Google Scholar : PubMed/NCBI

30 

Katikireddy KR and O'Sullivan F: Immunohistochemical and immunofluorescence procedures for protein analysis. Methods Mol Biol. 784:155–167. 2011. View Article : Google Scholar : PubMed/NCBI

31 

Feldman AT and Wolfe D: Tissue processing and hematoxylin and eosin staining. Methods Mol Biol. 1180:31–43. 2014. View Article : Google Scholar : PubMed/NCBI

32 

Uedo N and Yao K: Endoluminal diagnosis of early gastric cancer and its precursors: Bridging the gap between endoscopy and pathology. Adv Exp Med Biol. 908:293–316. 2016. View Article : Google Scholar : PubMed/NCBI

33 

Feliciano Cespedes EM, Kroenke CH, Bradshaw PT, Chen WY, Prado CM, Weltzien EK, Castillo AL and Caan BJ: Postdiagnosis weight change and survival following a diagnosis of early stage breast cancer. Cancer Epidemiol Biomarkers Prev. 26:44–50. 2016. View Article : Google Scholar : PubMed/NCBI

34 

Tada M and Koike K: Pancreatic tumor: Progress in diagnosis and treatment. Topics: II. Intraductal papillary mucinous neoplasm of the pancreas (IPMN)/mucinous cystic neoplasm (MCN); 1. Symptoms and surveillance of IPMN and MCN. Nihon Naika Gakkai Zasshi. 101:51–56. 2012.(In Japanese). View Article : Google Scholar : PubMed/NCBI

35 

Ji Y, Tan YS, Zhu XZ, Zeng HY, Kuang TT and Jin DY: Diagnosis and differential diagnosis of intraductal papillary mucinous neoplasm of pancreas. Zhonghua Bing Li Xue Za Zhi. 35:77–81. 2006.PubMed/NCBI

36 

Shah RB, Leandro G, Romerocaces G, Bentley J, Yoon J, Mendrinos S, Tadros Y, Tian W and Lash R: Improvement of diagnostic agreement among pathologists in resolving an ‘atypical glands suspicious for cancer’ diagnosis in prostate biopsies utilizing a novel ‘disease-focused diagnostic review’ quality improvement process. Hum Pathol. 56:155–162. 2016. View Article : Google Scholar : PubMed/NCBI

37 

Haider MA, Yao X, Loblaw A and Finelli A: Multiparametric magnetic resonance imaging in the diagnosis of prostate cancer: A systematic review. Clin Oncol (R Coll Radiol). 28:550–567. 2016. View Article : Google Scholar : PubMed/NCBI

38 

Ringold DA, Yen RD and Chen YK: Direct dorsal pancreatoscopy with narrow-band imaging for the diagnosis of intraductal papillary mucinous neoplasm and pancreas divisum (with video). Gastrointestinal Endosc. 72:1263–1264. 2010. View Article : Google Scholar

39 

Thestrup KC, Logager V, Baslev I, Møller JM, Hansen RH and Thomsen HS: Biparametric versus multiparametric MRI in the diagnosis of prostate cancer. Acta Radiol Open. 5:20584601166630462016.PubMed/NCBI

40 

Vargas HA, Schor-Bardach R, Long N, Kirzner AN, Cunningham JD, Goldman DA, Moskowitz CS, Sosa RE, Sala E, Panicek DM and Hricak H: Prostate cancer bone metastases on staging prostate MRI: Prevalence and clinical features associated with their diagnosis. Abdom Radiol (NY). 42:271–277. 2016. View Article : Google Scholar

41 

Moore CM and Taneja SS: Integrating MRI for the diagnosis of prostate cancer. Curr Opin Urol. 26:466–471. 2016. View Article : Google Scholar : PubMed/NCBI

42 

Li X, Welch EB, Chakravarthy AB, Xu L, Arlinghaus LR, Farley J, Mayer IA, Kelley MC, Meszoely IM, Means-Powell J, et al: Statistical comparison of dynamic contrast-enhanced MRI pharmacokinetic models in human breast cancer. Magn Reson Med. 68:261–271. 2012. View Article : Google Scholar : PubMed/NCBI

43 

Weigel MT, Meinhold-Heerlein I, Bauerschlag DO, Schem C, Bauer M, Jonat W, Maass N and Mundhenke C: Combination of imatinib and vinorelbine enhances cell growth inhibition in breast cancer cells via PDGFR beta signalling. Cancer Lett. 273:70–79. 2009. View Article : Google Scholar : PubMed/NCBI

44 

Cristofanilli M, Morandi P, Krishnamurthy S, Reuben JM, Lee BN, Francis D, Booser DJ, Green MC, Arun BK, Pusztai L, et al: Imatinib mesylate (Gleevec) in advanced breast cancer-expressing C-Kit or PDGFR-beta: Clinical activity and biological correlations. Ann Oncol. 19:1713–1719. 2008. View Article : Google Scholar : PubMed/NCBI

45 

Gehmert S, Prantl L, Vykoukal J, Alt E and Song YH: Breast cancer cells attract the migration of adipose tissue-derived stem cells via the PDGF-BB/PDGFR-beta signaling pathway. Biochem Biophys Res Commun. 398:601–605. 2010. View Article : Google Scholar : PubMed/NCBI

46 

Zhang YY, Liu ZB, Ye XG and Ren WM: Iodine regulates G2/M progression induced by CCL21/CCR7 interaction in primary cultures of papillary thyroid cancer cells with RET/PTC expression. Mol Med Rep. 14:3941–3946. 2016. View Article : Google Scholar : PubMed/NCBI

47 

Rotondi M, Coperchini F, Awwad O, Pignatti P, Di Buduo CA, Abbonante V, Magri F, Balduini A and Chiovato L: Effect of Interferon-γ on the Basal and the TNFα-stimulated secretion of CXCL8 in thyroid cancer cell lines bearing either the RET/PTC rearrangement or the BRAF V600e mutation. Mediators Inflamm. 2016:85124172016. View Article : Google Scholar : PubMed/NCBI

48 

Andreucci E, Francica P, Fearns A, Martin LA, Chiarugi P, Isacke CM and Morandi A: Targeting the receptor tyrosine kinase RET in combination with aromatase inhibitors in ER positive breast cancer xenografts. Oncotarget. 7:80543–80553. 2016. View Article : Google Scholar : PubMed/NCBI

49 

Baba T, Sakamoto Y, Kasamatsu A, Minakawa Y, Yokota S, Higo M, Yokoe H, Ogawara K, Shiiba M, Tanzawa H and Uzawa K: Persephin: A potential key component in human oral cancer progression through the RET receptor tyrosine kinase-mitogen-activated protein kinase signaling pathway. Mol Carcinog. 54:608–617. 2015. View Article : Google Scholar : PubMed/NCBI

50 

Inoue T, Hyodo T, Korenaga K, Murakami T, Imai Y, Higaki A, Suda T, Takano T, Miyoshi K, Koda M, et al: Kupffer phase image of Sonazoid-enhanced US is useful in predicting a hypervascularization of non-hypervascular hypointense hepatic lesions detected on Gd-EOB-DTPA-enhanced MRI: A multicenter retrospective study. J Gastroenterol. 51:144–152. 2016. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Sun M, Kang L, Cui Y and Li G: Application of a novel targeting nanoparticle contrast agent combined with magnetic resonance imaging in the diagnosis of intraductal papillary mucinous neoplasm Retraction in /10.3892/etm.2024.12720. Exp Ther Med 16: 1216-1224, 2018.
APA
Sun, M., Kang, L., Cui, Y., & Li, G. (2018). Application of a novel targeting nanoparticle contrast agent combined with magnetic resonance imaging in the diagnosis of intraductal papillary mucinous neoplasm Retraction in /10.3892/etm.2024.12720. Experimental and Therapeutic Medicine, 16, 1216-1224. https://doi.org/10.3892/etm.2018.6349
MLA
Sun, M., Kang, L., Cui, Y., Li, G."Application of a novel targeting nanoparticle contrast agent combined with magnetic resonance imaging in the diagnosis of intraductal papillary mucinous neoplasm Retraction in /10.3892/etm.2024.12720". Experimental and Therapeutic Medicine 16.2 (2018): 1216-1224.
Chicago
Sun, M., Kang, L., Cui, Y., Li, G."Application of a novel targeting nanoparticle contrast agent combined with magnetic resonance imaging in the diagnosis of intraductal papillary mucinous neoplasm Retraction in /10.3892/etm.2024.12720". Experimental and Therapeutic Medicine 16, no. 2 (2018): 1216-1224. https://doi.org/10.3892/etm.2018.6349
Copy and paste a formatted citation
x
Spandidos Publications style
Sun M, Kang L, Cui Y and Li G: Application of a novel targeting nanoparticle contrast agent combined with magnetic resonance imaging in the diagnosis of intraductal papillary mucinous neoplasm Retraction in /10.3892/etm.2024.12720. Exp Ther Med 16: 1216-1224, 2018.
APA
Sun, M., Kang, L., Cui, Y., & Li, G. (2018). Application of a novel targeting nanoparticle contrast agent combined with magnetic resonance imaging in the diagnosis of intraductal papillary mucinous neoplasm Retraction in /10.3892/etm.2024.12720. Experimental and Therapeutic Medicine, 16, 1216-1224. https://doi.org/10.3892/etm.2018.6349
MLA
Sun, M., Kang, L., Cui, Y., Li, G."Application of a novel targeting nanoparticle contrast agent combined with magnetic resonance imaging in the diagnosis of intraductal papillary mucinous neoplasm Retraction in /10.3892/etm.2024.12720". Experimental and Therapeutic Medicine 16.2 (2018): 1216-1224.
Chicago
Sun, M., Kang, L., Cui, Y., Li, G."Application of a novel targeting nanoparticle contrast agent combined with magnetic resonance imaging in the diagnosis of intraductal papillary mucinous neoplasm Retraction in /10.3892/etm.2024.12720". Experimental and Therapeutic Medicine 16, no. 2 (2018): 1216-1224. https://doi.org/10.3892/etm.2018.6349
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team